PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"
Nicolas Schlegel
336 participants
Jan 8, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.
Eligibility
Inclusion Criteria3
- Age ≥ 18 years
- Thyroidectomy or bilateral thyroid resection of any indication
- Written informed consent obtained after detailed patient information and provision of an information sheet
Exclusion Criteria7
- Age ≤ 18 years
- Concomitant parathyroid disease (primary or secondary hyperparathyroidism, pre-existing hypoparathyroidism of any cause)
- Previous surgery in the neck region
- Pregnancy or breastfeeding
- Inability to attend study visits
- Participation in another study that interferes with the endpoints
- Missing or inadequate patient information
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Application if parathyroid hormone level falls below normal
Administered if parathyroid hormone level falls below normal
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07491601